Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1 seropositive individuals

被引:28
作者
Ribas, SG
Ondoa, P
Schüpbach, J
van der Groen, G
Fransen, K
机构
[1] Inst Trop Med, B-2000 Antwerp, Belgium
[2] Univ Zurich, Swiss Natl Ctr Retroviruses, Zurich, Switzerland
关键词
HIV-1; RNA; viral load; heat-denatured p24 antigen; HIV subtypes;
D O I
10.1016/S0166-0934(03)00219-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The heat-denatured signal-amplified p24 antigen assay is a low-cost test allowing the determination of plasma levels of HIV-1 p24 antigen in infected patients. This assay may be appropriate for monitoring disease progression in HIV seropositive patients in developing countries. Only a few data on the clinical validation of the test are available for HIV-1 non-subtypes B viruses that represent the vast majority of virus circulating in Africa. The present study was undertaken to evaluate and compare the performance of a heat-denatured signal-amplified p24 assay for the determination of p24 viral load in the plasma of individuals infected with different subtypes of HIV-1 and using the RT-PCR-based RNA viral load test as the gold standard. A total of 120 plasma samples from individuals infected with HIV-1 strains belonging to group M (subtypes A --> H) and group O, as well as recombinant strains, were tested in parallel with the heat-denatured signal-amplified p24 assay and the RNA viral load. Plasma p24 levels appeared to be correlated significantly with the plasma RNA viral loads (R = 0.751, P < 0.0001). The heat-denatured p24 antigen assay was capable of measuring the plasma level of p24 derived from all the HIV-1 subtypes and recombinants selected for this study, in contrast to the RNA viral load test which lacked sensitivity towards HIV-1 group O. The heat-denatured signal-amplified p24 assay is a reliable, sensitive and a more affordable tool that can be used for the follow-up of patients infected with B and non-B subtypes as well as recombinant forms of HIV-1 in developing countries. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:29 / 34
页数:6
相关论文
共 24 条
[1]   CATALYZED REPORTER DEPOSITION, A NOVEL METHOD OF SIGNAL AMPLIFICATION - APPLICATION TO IMMUNOASSAYS [J].
BOBROW, MN ;
HARRIS, TD ;
SHAUGHNESSY, KJ ;
LITT, GJ .
JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 125 (1-2) :279-285
[2]   Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma [J].
Boni, J ;
Opravil, M ;
Tomasik, Z ;
Rothen, M ;
Bisset, L ;
Grob, PJ ;
Luthy, R ;
Schupbach, J .
AIDS, 1997, 11 (06) :F47-F52
[3]  
Bürgisser P, 2000, J ACQ IMMUN DEF SYND, V23, P138
[4]  
COFFIN JM, 1996, VIROLOGY, P767
[5]   DESIGN AND EVALUATION OF NEW, HIGHLY SENSITIVE AND SPECIFIC PRIMERS FOR POLYMERASE CHAIN-REACTION DETECTION OF HIV-1-INFECTED PRIMARY LYMPHOCYTES [J].
FRANSEN, K ;
ZHONG, P ;
DEBEENHOUWER, H ;
CARPELS, G ;
PEETERS, M ;
LOUWAGIE, J ;
JANSSENS, W ;
PIOT, P ;
VANDERGROEN, G .
MOLECULAR AND CELLULAR PROBES, 1994, 8 (04) :317-322
[6]  
Fransen K, 1997, J MED VIROL, V53, P31, DOI 10.1002/(SICI)1096-9071(199709)53:1&lt
[7]  
31::AID-JMV6&gt
[8]  
3.0.CO
[9]  
2-R
[10]  
GURTLER LG, 1994, J VIROL, V68, P1581